Abstract: The present disclosure relates to natural and/or homeopathic compositions comprising coconut oil in a form suitable for topical administration to a subject and having one or more health-promoting property, including those for treatment and/or prevention of disease, and methods for use thereof. The present disclosure further relates to natural and/or homeopathic compositions comprising coconut oil and optionally at least one additional active agent, which may impart natural, homeopathic, medicinal, pharmaceutical, and/or cosmetic properties, and methods for use thereof.

Abstract: Equipment for entering and exiting boats is addressed. Generally, the equipment is in the form of “divers' doors” for inflatable or similar boats. However, unlike existing inflatable doors, the doors discussed herein need not necessarily inflate. Instead, they may be formed as flaps moveable between closed and open positions. Ramped rub strakes or other aspects of the boats may assist in diverting water away from any gaps present when the flaps are closed but the boats are travelling at significant speeds.

Abstract: The present invention provides novel polynucleotides encoding LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: The present invention relates to KCNQ proteins defining potassium channels. In particular, the invention concerns the human KCNQ2, human KCNQ3, murine KCNQ2, and rat KCNQ2 proteins reported herein. KCNQ2 and KCNQ3 proteins are nervous system-selective and may be involved in neurotransmission and neuroprotection. The KCNQ2 and KCNQ3 of the present invention can be used to assay for modulators of the proteins, which would be useful in treatment of such disorders as ataxia, myokymia, seizures, Alzheimer's disease, Parkinson's disease, age-associated memory loss, learning deficiencies, motor neuron diseases, epilepsy, stroke, and the like.

Abstract: Equipment for entering and exiting boats is addressed. Generally, the equipment is in the form of “divers' doors” for inflatable or similar boats. However, unlike existing inflatable doors, the doors discussed herein need not necessarily inflate. Instead, they may be formed as flaps moveable between closed and open positions. Ramped rub strakes or other aspects of the boats may assist in diverting water away from any gaps present when the flaps are closed but the boats are travelling at significant speeds.